The Impact of HER2 Phenotype of Circulating Tumor Cells in Metastatic Breast Cancer: A Retrospective Study in 107 Patients

BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1423-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The HER2 Phenotype of Circulating Tumor Cells in HER2-positive Early Breast Cancer: A Translational Research Project of a Prospective Randomized Phase III Trial

PLoS ONE
Multidisciplinary
2017English

Retrospective Analysis of HER2 Therapy Interruption in Patients Responding to the Treatment in Metastatic HER2+ Breast Cancer

ESMO Open
Cancer ResearchOncology
2017English

53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients

Cancers
Cancer ResearchOncology
2020English

Effects of Herceptin on Circulating Tumor Cells in HER2 Positive Early Breast Cancer

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy® System in Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2019English

Correlation of HER2 Status Between Primary Tumors and Corresponding Circulating Tumor Cells in Advanced Breast Cancer Patients

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

Circulating Tumor Cells Detection in Tumor Draining Vein of Breast Cancer Patients

Scientific Reports
Multidisciplinary
2019English

Circulating Tumor Cells in Patients With Breast Cancer Dormancy

Clinical Cancer Research
Cancer ResearchOncology
2004English

Prognostic Impact of ANX7-GTPase in Metastatic and HER2-Negative Breast Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy